Single Ascending Dose Study With Healthy Male Volunteers and Type II Diabetic Patients

PHASE1TerminatedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
Type 2 Diabetes
Interventions
DRUG

AZD6714

Oral single doses a-h suspension

DRUG

Placebo

Oral single doses suspension

DRUG

AZD6714

Oral single doses a-d suspension

DRUG

AZD6714

Oral single doses d and g suspension

Trial Locations (1)

Unknown

Research Site, Gothenburg

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY